Apollo Medical Holdings, Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will present at the 41st Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 1:30 p.m. PT/4:30 p.m. ET. This participation signifies the company's commitment to engaging with investors and sharing its vision for value-based healthcare. Co-CEO Brandon Sim expressed excitement about being part of the conference and emphasized ApolloMed's goal of enabling high-quality care through technology. The conference runs from January 9-12, 2023, in San Francisco, and the presentation will be available via live webcast.
Details
News Market Reaction – AMEH
The recorded move for AMEH in the trading session of this news was -1.94%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALHAMBRA, Calif., Dec. 20, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is presenting at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 1:30 p.m. PT/4:30 p.m. ET.
"Being part of the JPM healthcare community for the second year in a row is very exciting to us as a growing team and organization. We're grateful for this opportunity to share our performance and vision with this key investor community and like-minded peers," said Brandon Sim, Co-CEO of ApolloMed. "Our team at ApolloMed is committed to enabling our providers to deliver high quality value-based healthcare to patients and build long-term value for our shareholders."
Leadership will also be participating in one-on-one meetings at this conference, which is taking place January 9-12, 2023, at the Westin St. Francis in San Francisco. The Company's presentation will be made available via live webcast and in archive following the conclusion of the events at the "Events" page of the Company's website: https://www.apollomed.net/news-media/events.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@apollomed.net
Carolyne Sohn, The Equity Group
(408) 538-4577
csohn@equityny.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-to-participate-in-41st-annual-jp-morgan-healthcare-conference-301706598.html
SOURCE Apollo Medical Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.